June 2014 -
Volume 7 Issue 2

Click the icon to view and download PDF of this journal issue

Current Issue
........................................

Original Contributon and Clinical Investigation

Biological markers study of acute and chronic myeloid leukemia
[pdf version]
Azhar Abbas Ismaeel

........................................

Models and Methods and
Clinical Research


Compared levels of specific divalent trace elements in hyperlipidemia and hepatitis sera patients
[pdf version]
Namama Soran H, Dler. M. Salh, Avan Arif A

Effects of Risedronate, Alendronate, and Raloksifene on Fracture Healing in Rats
[pdf version]
Raif Ozden, Vedat Uruc, Ibrahim Gokhan Duman, Yunus Dogramaci, Aydiner Kalaci, Erkam Komurcu,
Omer Serkan Yildiz, Ertugrul Sene


Nitric Oxide and Oxidative Stress Properties of L-Carnitine in Diabetic Hypertensive Rats Biochemical & Histological Study
[pdf version]
Mona Abd El-Latif Abuzahra, Sherifa Abd-Elsalam Mustafa


........................................
.

Chief Editor:
Ahmad Husari MD FCCP D'ABSM
........................................

Publisher:
Lesley Pocock
medi+WORLD International
11 Colston Avenue
Sherbrooke 3789
AUSTRALIA
Phone: +61 (3) 9005 9847
Fax: +61 (3) 9012 5857
Email
: lesley@mediworld.com.au

........................................

Editorial enquiries:
editor@me-jim.com

........................................

Advertising Enquiries:
lesley@mediworld.com.au
........................................

While all efforts have been made to ensure the accuracy of the information in this journal, opinions expressed are those of the authors and do not necessarily reflect the views of The Publishers, Editor or the Editorial Board. The publishers, Editor and Editorial Board cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; or the views and opinions expressed. Publication of any advertisements does not constitute any endorsement by the Publishers and Editors of the product advertised.

The contents of this journal are copyright. Apart from any fair dealing for purposes of private study, research, criticism or review, as permitted under the Australian Copyright Act, no part of this program may be reproduced without the permission of the publisher.

 

Journal Edition - June 2014 - Volume 7, Issue 2

Biological markers study of acute and chronic myeloid leukemia

......................................................................................................................................................................

Azhar Abbas Ismaeel


Correspondence:
Azhar Abbas Ismaeel
College of Education for pure Science, Ibn Al-Haitham, Department of Chemistry, Biochemistry Laboratory,
University of Baghdad, Iraq
Email:
Azhar.almula@yahoo.com

ABSTRACT

Twenty two acute myelogenous leukemia (AML) patients and 20 chronic myelogenous leukemia (CML) patients, were admitted to Medical City Hospital, in addition to 35 healthy individuals as the control group. Vitamin C and vitamin D, trace and essential elements cobalt, and Nickel magnesium were evaluated in the sera of all above individuals, using high performance liquid chromatography and atomic absorption spectrophotometry for evaluating vitamins and elements. The results revealed a a significant decrease in vitamin C and vitamin D and Mg levels in both patients groups compared to controls and a significant difference in CO and Ni levels in sera of AML and CML was found.

Conclusion: Vitamins, trace and essential elements abnormalities occur in both patient groups compared to Controls.

Key words : Acute, Chronic leukemia, vitamins C, D, cobalt, Nickel, Magnesium


INTRODUCTION

Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts. It is classified into several types. Acute and chronic could be considered as the essential type and includes many types under each term such as lymphocytic, granulocytic and monocytic leukemia((1). Acute leukemia, is one of the two major categories of leukemia, with symptoms including anemia, fatigue, weight loss, easy bruising, thrombocytopenia, and granulocytopenia ,while chronic leukemia is characterized by the excessive build up of relatively mature, but still abnormal, white blood cells (2). The maintenance of optimal health proteins, lipids, macronutrients, micronutrients, vitamins and trace elements.(3) Vitamins are an organic compound required by an organism as a vital nutrient. In limited amounts ,vitamins serve multiple roles and they work together to perform many functions, from reducing infection to aiding metabolism. (4) Vitamin C (Ascorbic Acid) is an important antioxidant found in the biological system. It is the first line antioxidant defense in plasma.( 5) Proposed mechanisms of vitamin C activity in the prevention and treatment of cancer include : enhancement of the immune system by increased lymphocyte production, stimulation of collagen formation necessary for "walling off" tumors , inhibition of hyaluronidase, keeping the ground substance around the tumor intact and preventing metastasis, inhibition of oncogenic viruses, correction of an ascorbic deficiency, and is often seen in cancer patients.(6,7,8)

Cholecalciferol is a prohormone that is synthesized in the skin by photochemical conversion of 7-dehydrocholesterol. It is subsequently hydroxylated to 25-hydroxycholecalciferol [25(OH)D3] in the liver and in the kidney finally to the active metabolite, 1,25 didydroxcholecalciferol [1,25(OH)2D3. ( 9 ,10)

Trace elements (TE) are a group of elements that are present in the human body in very small amounts (milligrams per day), but are nonetheless important to good health. ( 11)Their action is that (TE) are constituents of, or interact with enzymes, cofactors, phosthetic groups or hormones that regulate the metabolism of much larger amounts of biochemical substrates(12 ).

Cobalt is an essential element for humana, as a part of vitamin B12 (coblamin) - micro flora of the lumen intestine.1(13,14,15,)

Nickel is one of the ultra trace elements; Nickel ions used in the iron transport system across small intestine related with ferritin, thereby cause anemia;the deficiency of nickel causes alteration of folate and vitamin C.(16)
Magnesium (Mg) is essential to the basic nucleic acid chemistry of life and thus is essential to all known living organisms. Mg is important for maintaining of DNA. Magnesium is extremely necessary for proper ATP synthesis(17,18,19).

AIM OF STUDY

The aim of the study is to evaluate vitamin C, vitamin D and trace and essential elements of Co, Ni, Mg, levels in the sera of patients with acute and chronic leukemia compared to controls.

- Experimental Part
- Subjects:

Blood samples were collected from the patients with acute myelogenous leukemia (AML) and patients with chronic myeloblastic leukemia (CML) from men, who were admitted to Medical City Hospital. Their age range was 32-52 years. The patients were diagnosed by specialist doctors. Thirty five healthy individuals were matched aged 30-50.

Instrumentation : Vitamin C was measured using high performance liquid chromatography ( Shimadzu Japan C18 column). Vitamin D was separated on FLC (Fast liquid chromatograph column) 3µm particle size stored column, obtaining optimum conditions, temperature, flow rate, eluent composition were used for detection of vitamins . The concentration of each vitamin was estimated through measurement of area under the curve of chromatograms of standard vitamins and for patients and control serum samples.

Cstandard = Standard concentration of the measured vitamin in ug/ml.
Vitamin concentration in ug/ml = Asample x Cstandard
...................................................Astandard
Asample = Area under the curve of sample.
Astandard = Area under the curve of standard

Atomic absorption spectrophotometry (model AA46-schma-dzo-japan{AAS) : AAS was used for determination of CO, Ni and Mg. A standard calibration curve is used for measurement of CO, Ni and Mg in the sera of groups under this study AML, CML, and controls.

Statistical analysis
The means and standard deviations, and student t test was used to compare the significance of the difference in the mean values of any two groups.

(P < 0.05) was considered statistically significant (20).

RESULT AND DISCUSSION

Table 1 shows low serum levels of vitamin C (3.06, 3.46 µg|ml) for AML, ACML compared with controls (4.2µg|ml).

It was reported that toxic reactive oxygen species increase during leukemia(21). Ascorbate is a powerful reducing agent capable of rapidly scavenging a number of reactive oxygen species, so our results are in agreement with results which illustrated that the cancer incidence and mortality is associated with low levels of ascorbic acid.(22) We can speculate that this protective effect may occur through antioxidant pathways or through enhancement of immune function. (21) There is also some recent evidence suggesting that ascorbate exerts a selective cytotoxic effect against malignant cells; all these observations indicate that supplemental ascorbate should be of some therapeutic value in the treatment of cancer.( 22)

Table 1 shows levels of vitamin D (3.46, 3.63 µg|ml) for AML, ACML compared with controls (4.73µg|ml). The reduction of vitamin D level in AML and CML is in agreement with Drake, MT, Maurer MJ(23). Numerous epidemiological and preclinical studies support a role of vitamin D compounds in cancer prevention and treatment in colorectal, breast, prostate, ovarian, bladder, lung and skin cancers and leukemia(24 ).The newly recognized use of 1,25(OH)2D3 analogues as immunomodulatory agents is based on the ability of these analogues to influence gene expression in cells of the immune system and cytokine expression by other cells(25). In addition some non traditional roles ascribed to vitamin D include anti-flammatory and immune-modulating effects. (26)

Table 1: Serum concentration (µg|ml ) of vitamin C and D in AML, CML and healthy control group.


Table 2 shows the results of cobalt, Nickel and magnesium, levels in sera of controls, AML and CML groups. The result of cobalt level in serum of patients with AML, CML, were (0.012 58 , 0.0154 ug/l ), respectively, which are lower than serum level of controls ( 0.027930 ug/l). This result is in agreement with published results (0.03 ug/l) (27). It appears that the depletion of Cobalt in serum of patients is related to vitamin B12. (15) In addition, biological research that has been done suggests a relationship between cobalt and cancer(28).

Table 2: The serum concentration( µg|l) of CO, Ni and Mg in AML, CML and healthy control group
P* value between AML and CML

The Nickel level in serum of patients with Acute CML were 0.01163 and 0.01390 respectively, which is lower than level in serum of controls, ( 0.01445 ug/l). This result is compared with Nickel level of patients and controls with published values ( 0.3 ug/l ) (29, 15 ). In another study, high serum concentration of Nickel causes cancer because itdamages the chromosomes , and on a molecular basis Nickel induces DNA damage (DNA strand breaks and crosslink's infidelity of DNA replication, inhibition of DNA repair, and the helical of B-DNA to Z-DNA ) by binding Nickel to the nuclear protein ( 30 ). These events reflected the effects of Nickel in two states of concentrations, in the statement of exposure to and the statement of lower levels, tended to cause cancer (31).

The Mg level in patient groups is significantly lower than controls. The decrease in Mg concentration in the many studies suggests the diminished Mg due to the high ATP requirement of the leukemia since Mg is known to be an important part as a cofactor in most of the energy producing reactions(32).

Figure 1, Figure 2 and Table 3 show the correlation relation between vitamin D and CO, Ni in sera of AML, CML and healthy control group; positive correlation between vitamin D and CO, Ni in healthy control group with r values (0.987,0.799), positive correlation between vitamin D and CO in AML and CML with r values (0.980,0.970); positive correlation between vitamin D and Ni in AML and CML with r values (0.948, 0.870)

Table 3: Correlation relation between Vitamin D and Co, Ni in AML, CML and healthy control group.



Figure 1


Figure 2

REFERENCES

1- Meson, J. N. St C.; Dennis L. Kasper; Harrison, Tinsley Randolph; Braunwald, Eugene; Fauci, Anthony S.; Hauser, Stephen L; Longo, Dan L . Harrison's principles of Internal medicine. New York2005, Medical Publishing .
2- Colvin G. A., Elfenbein G. J. The latest treatment advances for acute myelogenous leukemia. Medicine and Health, Rhode Island 86 (8): 243-6 . . 2003
3- Bender, David A.. Nutritional biochemistry of the vitamins. Cambridge, U.K.: Cambridge University Press 2003.
4- Lieberman, S and Bruning, N. The Real Vitamin & Mineral Book. NY: 1990.
5- Halliwell B. Biochemistry of oxidative stress. Biochemical Society Transactions, 35, 1147-1150, 2007.
6- Basnet P, Norsk farmaceutisk tidsskrift Vitamin C prevention of chronic Disease and optimal Doses, 9; 20-24, 2010
7- Kathleen A. Head, ND. Ascorbic Acid in the Prevention and Treatment of Cancer, 2004
8- Akoury, N.E. Willy High dose Vitamin C is an Alternative cancer treatment 2012.
9- Binkley, N. , R. Ramamurthy, L ow vitamin D status: definition, prevalence, 2010.
10- Holick M. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes;9:87-98 2002
11- Somous N. "Trace elements . in clinical nutrition : parenteral in medical practice " , 4th ed , Royal P.M.S,London,P.442 ;1977 nutrition ' 2nd edition. Philadelphia 156 - 183,1993
12- Harrison PM,Arson p. The ferrins; molecular properties, iron storage function and cellular regulation. biocembiophy s Acta ; 275 . 161-203,1996
13- Nasri H. Chelation, Downloads, Erythrocyte (Red Blood Cell) Essential & Toxic Elements, PP.1-3 . 2006
14- Atlanta GA ., Agency for Toxic Substances and Disease Registry ( ATSDR), P1- 2 . 2001,
15- S. Hosokawa, H. Nishitian , K. Umemura, T .Tomoyoshi , K. Sawanishi and O. Yoshida , (International Urology and Nephrology SpringerLink- Journal Article), 447 - 451 .2007.
16- Hopfer SM, Fay WP. Sunderman FW Jr ., Ann . Clin . Lab. Sci ., , 19 , 161- 167 . 1989
17- Jane Hidon, Ph.D. Linus Pauling Institute Oregon State University "Magnesium",2003
18- Hartwig A. Role of magnesium in genomic stability mutate. Res 475:113 - 121 , 2001
19- A.L Buchachenkoa, L.N. Schegolerab and N.N. Breslavrakyca paramagnetic complex of magnesium as mediators in enzymetic ATP synthesis, 2009
20- Bailey N.I Statistical methods in biology; Ltd press.,1974. 20- 0
21- Richterc, Gogvadzev, Laffranchi R, Biochem. Biophy ra ; Orlando- S-F; Boldt, David H, Br-J-Haematol - 117: 727 ,2002
22- Mallery DL, McEwan WA, Bidgood SR, Towers GJ, Johnson CM and James LC. Antibodies mediate intracellular immunity through tripartite motif containing 16; 107(46):19985-90.21 2010.
23- Drake, M. T., M. J. Maurer, Vitamin D insufficiency. 2010
24- Harrison JS, Bershadskiy A. Leuk Res Treatment. , 2012 .
25- Holick, M. F. Vitamin D: evolutionary, physiological and health perspectives." CurrDrug Targets 12 ,14-18. 2011 .
26- Gueli, N., W. Verrusio. Vitamin D: drug of the future. A new therapeutic. 2011.
27- H. M.Shen and Q.F. Zhang , Environ Health Perspect , 102 , Suppl 1 , 275-282 . 1994
28- Sheppard, P.R., R.J. Speakman, G. Ridenour, and M.L. Witten. Temporal variability of tungsten and cobalt in Fallon, Nevada. Environmental Health Perspectives 115:715-719. 2007.
29- Evert Nieboer and Jon Oyvind Odland, Physician copy - Nickel, Oslo, April 11, pp.785 - 796. 2001.
30- J.M. Christensen , J. Kristiansen , N.H. Nielsen, T. Menne and Byrialsen , Toxylogy Letter, 108, Issues 2-3, 185- 189 ,2000.
31- Swain R., J Fam Pract, 41, 6 , 595- 600 ,1995.
32- J. Durlach, P. Rinjard, M. Bara, A. Guiet-Bara, and P. Collery, in Magnesium: Physiologische Aspekte für die Praxis (B. Lasserre, ed.), Panscientia Verlag, Hedzingen-Zürich, 1987

 

 
 


Home
: About MEJFM : Journal : Advertising :
Author Information : Editorial Board : Resources : Contact Details
Disclaimer © Copyright 2007 medi+WORLD International Pty. Ltd. All rights reserved